Telomerase activation in in Vitro and in Vivo cervical carcinogenesis

Gynecologic Oncology

Volumn 66, Issue 2, 1997, Pages 222-226

  Zheng, Peng Sheng ^a   Iwasaka, Tsuyoshi ^a   Yokoyama, Masatoshi ^a   Nakao, Yoshifumi ^a   Pater, Alan ^b   Sugimori, Hajime ^a  

^a SAGA UNIVERSITY   (Japan)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE CONDENSATE; TELOMERASE;

ADULT; ARTICLE; CANCER DIAGNOSIS; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROGNOSIS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

EID: 0031214202     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4757     Document Type: Article

References (42)

1. Gregg B M. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell. 59:1989;521-529.
2. Blackburn E H. Structure and function of telomeres. Nature. 350:1991;569-573.
3. Vaziri H, Schachter F, Wei L, Zhu X, Effros R, Cohen D, Harley C B. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet. 52:1993;661-667.
4. Lundblad V, Szostak J W. A mutant with a defect in telomere elongation leads to senescence in yeast. Cell. 57:1989;633-643.
5. Vaziri H, Dragowska W, Allsopp R C, Thomas T E, Harley C B, Lansdorp P M. Evidence for a mitotic clock in human hematopoietic stem cells, loss of telomeric DNA with age. Proc Natl Acad Sci USA. 91:1994;9857-9860.
6. Harley C B, Vaziri H, Counter C M, Allsopp R C. The telomere hypothesis of cellular ageing. Exp Gerontol. 27:1992;375-384.
7. Allsopp R C, Vaziri H, Patterson C, Goldstein S, Younglai E V. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA. 89:1992;10114-10118.
8. Counter C M, Avilion A A, Lefeuvre C E, Stewart N G, Greider C W, Harley C B, Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11:1992;1921-1929.
9. Counter C M, Botelho F M, Wang P, Harley C B, Bacchetti S. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol. 68:1994;3410-3414.
10. Rhyu M S. Telomeres, telomerase, and immortality. J Natl Cancer Inst. 87:1995;884-894.
11. Kim S W, Piatyszek M A, Prowse K R, Harley C B, West M D, Ho P LC, Coviello G M, Wright W E, Weinrich S L, Shay J W. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
12. Healy K C. Telomere dynamics and telomerase activation in tumor progression: prospects for prognosis and therapy. Oncol Res. 7:1995;121-130.
13. Parkin D M, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 54:1993;594-606.
14. Weinberg R A. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res. 49:1989;3713-3721.
15. Chen T, Pecoraro G, Defendi V. Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells. Cancer Res. 53:1993;1167-1171.
16. Scully R E, Bonfiglio T A, Kurman R J, Silverberg S G, Wilkinson E J. Epithelial Tumours and Related Lesions. Histological Typing of Female Genital Tract Tumours. 1994;Springer-Verlag, Berlin/New York. p. 39-43.
17. Negrini B P, Schiffman M H, Kurman R J, Barnes W, Lannom L, Malley K. Oral contraceptive use, human papillomavirus infection, and risk of early cytological abnormalities of the cervix. Cancer Res. 50:1990;4670-4675.
18. Gloria Ho YF, Burk R D, Klein S, Kadish A S, Chang C J, Palan P, Basu J, Tachezy R, Lewis R, Romney S. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 8:1996;1365-1371.
19. Nasiell K, Nasiell M, Vaclavinkova V. Behavior of moderate cervical dysplasia during long-term follow-up. Obstet Gynecol. 61:1983;609-614.
20. Harley C B, Kim N W, Prowse K R, Weinrich S L, Hirsch K S, West M D, Bacchetti S, Hirte H W, Counter C M, Greider C W, Piatyszek M A, Wright W E, Shay J W. Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol. 59:1994;307-315.
21. Boyce S T, Ham R G. Cultivation, frozen storage, and clonal growth of normal human epithelial keratinocytes in serum-free media. J Tissue Cult Methods. 9:1985;83-93.
22. Tsutsumi K, Belaguli N, Sun Q, Michalak T I, Gulliver W P, Pater A, Pater M M. Human papillomavirus 16 DNA immortalizes two types of normal human epithelial cells of the uterine cervix. Am J Pathol. 140:1992;255-261.
23. Tsutsumi K, Sun Q, Belaguli N S, Pater M M, Pater A. Distinct squamous phenotypes of human ectocervical cell lines immortalized by human papillomavirus type 16. Mol Cell Differ. 2:1994;141-157.
24. Sun Q, Tsutsumi K, Kelleher M B, Pater A, Pater M M. Squamous metaplasia of normal and carcinoma in situ of HPV 16-immortalized human endocervical cells. Cancer Res. 52:1992;4254-4260.
25. Yokoyama M, Tsutsumi K, Pater A, Pater M M. Human papillomavirus 18-immortalized endocervical cells with in vitro cytokertatin expression characterics of adenocarcinoma. Obstet Gynecol. 83:1994;197-204.
26. Nakao Y, Yang X, Yokoyama M, Pater M M, Pater A. Malignant transformation of human ectocervical cells immortalized by HPV 18: In vitro model of carcinogenesis by cigarette smoke. Carcinogenesis. 17:1996;577-583.
27. Shindoh M, Sun Q, Pater A, Pater M M. Prevention of carcinoma in situ of human papillomavirus type 16-immortalized human endocervical cells by retinotic acid in organotypic raft culture. Obstet Gynecol. 85:1995;721-228.
28. Yang X, Jin G, Nakao Y, Rahimtula M, Pater M M, Pater A. Malignant transformation of HPV16-immortalized human endocervical cells by cigarette smoke condensate and characterization of multistage carcinogenesis. Int J Cancer. 65:1996;338-344.
29. Stanley M A, Browne H M, Appleby M, Minson A C. Properties of a non-tumorigenic human cervical keratinocyte cell line. Int J Cancer. 43:1989;672-676.
30. Iwasaka T, Ouchida M, Matsuo N, Yokoyama M, Fukuda K, Hara K, Fukuyama K, Hori K, Sugimori H. Correlation between HPV positivity and state of the p53 gene in cervical carcinoma cell lines. Gynecol Oncol. 48:1993;104-109.
31. Crook T, Wrede D, Vousden K H. p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene. 6:1991;873-875.
32. Pater M M, Pater A. Human papillomavirus types 16 and 18 sequences in carcinoma cell lines of the cervix. Virology. 145:1985;313-318.
33. 53. EMBO J. 1:1982;1055-1062.
34. 53. Mol Carcinog. 4:1991;171-175.
35. Piatyszek M A, Kim S W, Weinrich S L, Hiyama K, Hiyama E, Wright W E, Shay J W. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci. 17:1995;1-15.
36. Zheng P S, Iwasaka T, Yamasaki F, Ouchida M, Yokoyama M, Nakao Y, Fukuda K, Matsuyama T, Sugimori H. Telomerase activity in gynecologic tumors. Gynecol Oncol. 64:1997;171-175.
37. Shay J W, Wright W E. Telomerase activity in human cancers. Curr Opin Oncol. 8:1996;66-71.
38. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay J W, Tahara E, Kajiyama G, Ide T. Telomerase activity in human liver tissue: Comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res. 55:1995;2734-2736.
39. Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA. 90:1996;6476-6481.
40. Blasco M A, Rizen M, Greider C W, Hanahan D. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet. 12:1996;200-204.
41. Klingelhutz A J, Foster S A, McDougall J K. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature. 380:1996;79-82.
42. Nelson N J. Researchers debate clinical role of telomerase. J Natl Cancer Inst. 88:1996;1021-1023.